Navigation Links
Diversionary Therapy Announces First Sale of ditto™ dental
Date:5/22/2012

NEW YORK, May 22, 2012 /PRNewswire/ -- Diversionary Therapy Technologies (DTT) is pleased to announce the first sale of its innovative new product, ditto™ dental, to Manhattan Pediatric Dental Group PC.   "We're excited to add ditto dental to our state-of-the-art pediatric dental care.  We trialed it in our office and had spectacular results," states Dr. Mark Hochberg, principal, of Manhattan Pediatric Dental Group.

ditto™ dental is a clinical tool developed from medical research which has been shown to reduce anxiety and stress for children aged 3-14 years. The procedural stories, covering all dental procedures, are chosen from the dentist menu to help prepare the children and their families for their treatment. By showing the videos before the procedure, treatment times have been shortened, anxiety reduced and better overall patient outcomes have resulted.  The portable device uses augmented reality, a multi-modal sensory-based distraction medium to engage children.  The user interface has other fun tangible interaction thanks to the touch screen and the motion sensors and can be used in a variety of positions.

Dr. Hochberg also added, "Taking your child to the dentist can be a very stressful experience for some children. It is important for us to be able to manage the child and reduce their apprehension during pediatric dental procedures.  We have purchased several devices because we found that showing the ditto™ dental pre-procedural videos helped relieve anxiety and lead to a better patient outcome."

The console also includes interactive games and immersive stories to engage the patient while waiting for procedures.  Pediatric dentists, orthodontists, child life specialists and animation experts have developed the ditto™ dental over the past couple of years and new content will continue to be added.

DTT will formally debut the ditto™ dental at the American Academy of Pediatric Dentistry 65th Annual Session in San Diego May 24-27. "We're looking forward to showing our device to over 2500 of the leading pediatric dentists in the United States.  We've had great feedback so far and it should be an exciting experience," say Steven Jenkins, CEO of DTT's North American operations.   

About Diversionary Therapy Technologies

Diversionary Therapy Technologies is a global company headquartered in Australia that masterminded the development of ditto™ portable device.  DTT worked with The Royal Children's Hospital, Brisbane, to create the handheld, waterproof device that is used prior to and during painful medical procedures to reduce children's anxiety.  Learn more at www.dtt-usa.com.

About Manhattan Pediatric Dental Group PC

Manhattan Pediatric Dental Group has provided the children of New York, and surrounding areas with the highest standard of state-of-the-art pediatric dental care for over 25 years. You can visit them at www.smiles4kids.com.


'/>"/>
SOURCE Diversionary Therapy Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
2. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
3. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
4. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
5. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Progenitor Cell Therapy Secures Industry Accreditation
8. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
9. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):